Capio Biosciences, a startup company from Chicago that is working to fight cancer, moved to Madison on Jan. 1.
Cofounder and president Seungpyo Hong has also joined UW–Madison as a pharmaceutical sciences professor, according to the Wisconsin State Journal.
Hong and cofounder Andrew Wang, an associate professor of radiation oncology at the University of North Carolina–Chapel Hill, started the company in 2013 and are renting space in the MGE Innovation Center at University Research Park.
Their technology can identify cancer cells in the bloodstream from blood samples, or “liquid biopsies.”
Advertisement
